All we have been hearing from these vaccine promoters is "trust the science", but are you going to "trust the science" when children in Africa ended up with debilitating polio after being vaccinated? The way Japanese have been socially engineered millions of Japanese will be clamoring in line for a coronavirus vaccine. There is so much wrong with the content of this Japan Times article where does one even begin?
As a business model, the Japanese have been the most aggressive in promoting immunizations under the euphemism of "socially responsible investing." Immunizations are an incredibly lucrative market for Japanese industrial investors including Dai-ichi Life, the third largest insurer in Japan. Industrial investors outside of Japan and domestic investors are heavily invested in Uridashi vaccine bonds. Damn the science on coronavirus vaccines because if they discovered the coronavirus vaccines are a liability and are dangerous, the Uridashi bond market would crash. Japan's mercantilist leadership knows this which explains Japan's seemingly bizarre behavior concerning masks. It's a marketing ploy and nothing more. So put your mask on, start conforming and get invested.
Under the magic spell of COVID, a mask is a perfect match for the Japanese psyche: they don't have to be forced to interact with others. Regardless whether or not masks are meant to prevent the spread of the COVID global business model (who tweaked a coronavirus in Wuhan?) under the WEF's dystopian "Great Reset," the Japanese have reacted in an entirely predictable way. In fact, each country is imitating the actions of other countries in regards to COVID and takes on different forms of bureaucratic control like it did in Japan.
________
Source: The Japan Times
Coronavirus vaccine pre-orders worldwide top 5 billion
August 12, 2020
WASHINGTON – Although none of the coronavirus vaccines under development has proved its efficacy yet in clinical trials, at least 5.7 billion doses have been pre-ordered around the world.
First shipments of a COVID-19 vaccine created by Western laboratories have often been snapped up by the United States.
Five vaccines — three Western and two Chinese — are in Phase 3 efficacy trials involving thousands of people.
In a surprise announcement, Russian President Vladimir Putin claimed Tuesday that a vaccine dubbed Sputnik V — after the Soviet satellite — conferred “sustainable immunity” against the novel coronavirus.
As research laboratories around the world race to develop a vaccine, manufacturers have received financing to help them prepare to have millions of doses ready to administer in 2021 or even before the end of the year.
Oxford University, working with the Swedish-British pharmaceutical group AstraZeneca, hopes to have results by September, while the US biotech company Moderna, partnering with the U.S. National Institutes of Health (NIH), is aiming for the end of the year, possibly November.
U.S. President Donald Trump has launched "Operation Warp Speed" in a bid to develop, manufacture and distribute a COVID-19 vaccine to all Americans by January 2021.
Hundreds of millions of dollars have been directed to vaccine developers, including nearly $500 million to Johnson & Johnson at the end of March.
The United States has allocated funding to more companies than any other nation in the hope that one of them will come up with the vaccine to counter the highly contagious virus.
So far, Washington has handed out at a total of at least $9.4 billion to seven vaccine developers and signed manufacturing contracts with five of them to provide 700 million doses.
The companies involved are: Johnson & Johnson, Moderna, Oxford/AztraZeneca, Novavax, Pfizer/BioNTech, Sanofi/GSK, Merck Sharp and Dohme.
Lab technicians use microscopes during production of a COVID-19 vaccine in Zelenograd, Russia. | BLOOMBERG
WASHINGTON – Although none of the coronavirus vaccines under development has proved its efficacy yet in clinical trials, at least 5.7 billion doses have been pre-ordered around the world.
First shipments of a COVID-19 vaccine created by Western laboratories have often been snapped up by the United States.
Five vaccines — three Western and two Chinese — are in Phase 3 efficacy trials involving thousands of people.
In a surprise announcement, Russian President Vladimir Putin claimed Tuesday that a vaccine dubbed Sputnik V — after the Soviet satellite — conferred “sustainable immunity” against the novel coronavirus.
As research laboratories around the world race to develop a vaccine, manufacturers have received financing to help them prepare to have millions of doses ready to administer in 2021 or even before the end of the year.
Oxford University, working with the Swedish-British pharmaceutical group AstraZeneca, hopes to have results by September, while the US biotech company Moderna, partnering with the U.S. National Institutes of Health (NIH), is aiming for the end of the year, possibly November.
U.S. President Donald Trump has launched "Operation Warp Speed" in a bid to develop, manufacture and distribute a COVID-19 vaccine to all Americans by January 2021.
Hundreds of millions of dollars have been directed to vaccine developers, including nearly $500 million to Johnson & Johnson at the end of March.
The United States has allocated funding to more companies than any other nation in the hope that one of them will come up with the vaccine to counter the highly contagious virus.
So far, Washington has handed out at a total of at least $9.4 billion to seven vaccine developers and signed manufacturing contracts with five of them to provide 700 million doses.
The companies involved are: Johnson & Johnson, Moderna, Oxford/AztraZeneca, Novavax, Pfizer/BioNTech, Sanofi/GSK, Merck Sharp and Dohme.
Please go to The Japan Times to read the entire article.
________
Related:
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.